Definitive Health Q2 Revenue Beats Expectations: Why I’m Upgrading The Stock To A Hold

view original post

Definitive Health beats on Q2 revenue and EPS, but weak Life Sciences subscriptions and structural pressures remain. Read why DH stock is a hold.